Price movement over the last 24 hours
American International Group Inc vs Ginkgo Bioworks Holdings Inc — how do they compare? American International Group Inc trades at $79.57 (market cap $42.98B), while Ginkgo Bioworks Holdings Inc trades at $8.93 (market cap $610.13M). The key difference: American International Group Inc is far larger — about 70.4× Ginkgo Bioworks Holdings Inc's market cap, and American International Group Inc pays a 2.47% dividend while Ginkgo Bioworks Holdings Inc pays none. Which is the better fit depends on your goals.
| AIG | DNA | |
|---|---|---|
Market Cap | $42.98B | $610.13M |
Sector | Financials | Health |
52-Week High | $86.59 | $16.14 |
52-Week Low | $71.89 | $5.48 |
Enterprise Value | $50.68B | $647.37M |
Dividend Yield | 2.47% | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
DNA trades at $10.11, down 2.79% today, with a bullish technical signal from moving averages but mixed oscillators. The company reported a net loss of $312.76M on $170.16M revenue in 2025, with negative cash flow and declining revenue projected into 2026. Recent news highlights include Ginkgo Bioworks' pivot to autonomous labs and insider selling activity, while analyst consensus shows a divided outlook with 45% buy ratings.
The outlook remains challenging due to persistent losses and cash burn, though technical strength offers short-term support. Investment opportunity hinges on successful execution of the autonomous lab strategy, while risks include continued negative margins, high cash consumption, and competitive pressures in biotechnology.
Trailing returns across standard periods
American International Group is one of the largest insurance and financial services firms in the world and has a global footprint. It operates through a wide range of subsidiaries that provide property, casualty, and life insurance. Its revenue is split roughly evenly between commercial and consumer lines.
Read more on AIG →Ginkgo Bioworks is a leading horizontal platform for cell programming. It uses advanced automation and software to design custom organisms for customers across diverse industries, including food, agriculture, and pharma.
Read more on DNA →